Announcement of the Board of Directors of the consolidated financial statements for Q3 2021

0

close

Supplied by: Standard Chemical & Pharmaceutical Co. Ltd.

SEQ_NO

1

Announcement date

2021/11/02

Announcement time

15:09:44

Topic

 Announcement of the board approved of the
2021Q3 consolidated financial statements

Date of events

2021/11/02

What element he answers

paragraph 31

Declaration

1.Date of submission to the board of directors or approval by the board of
 directors:2021/11/02
2.Date of approval by the audit committee:2021/11/02
3.Start and end dates of financial reports or annual self-assessed financial
 information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/1/1~2021/09/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):3371013
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):1526457
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):634029
7.Profit (loss) before tax accumulated from 1/1 to end of the period
 (thousand NTD):747177
8.Profit (loss) accumulated from 1/1 to end of the period
 (thousand NTD):625114
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):533781
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):2.99
11.Total assets end of the period (thousand NTD):7410775
12.Total liabilities end of the period
(thousand NTD):2267792
13.Equity attributable to owners of parent end of the
period (thousand NTD):4162403
14.Any other matters that need to be specified:NA

Disclaimer

Standard Chemical & Pharmaceutical Co. Ltd. published this content on November 02, 2021 and is solely responsible for the information it contains. Distributed by Public, unedited and unmodified, on 02 November 2021 07:38:08 UTC.

Public now 2021

All news about STANDARD CHEM & PHARM CO., LTD.
03: 39a Announcement of the Board of Directors of the consolidated financial statements for Q3 2021

EU

08/24 Standard Chem & Pharm Co., Ltd. announces the creation of an audit committee with Independen.

THIS

08/24 Standard Chem & Pharm Co., Ltd. replaces Mei-Ju, Shen with Shaw-Tzong, Liu as a member of ..

THIS

04/08 Standard Chem & Pharm CO., LTD. Announces results for the second quarter ended J.

THIS

04/05 Standard Chem & Pharm Co., Ltd. publishes its results for the first quarter ended.

THIS

03/16/16 Standard Chem & Pharm Co., Ltd. publishes its results for the year ended in December.

THIS

03/16/16 SYN-TECH Chem. & Pharma. Co., Ltd. has agreed to acquire Standar’s API synthesis department.

THIS

2020 Standard Chem & Pharm Co., Ltd. publishes its results for the third quarter ended.

THIS

2020 Standard Chem & Pharm Co., Ltd. publishes its results for the second quarter ended J.

THIS

2020 Standard Chem & Pharm Co., Ltd. publishes its results for the first quarter ended.

THIS

Sales 2020 4,305 million
155 million
155 million
2020 net income 524 million
18.8 million
18.8 million
2020 net cash position 696 million
25.0 M
25.0 M
PER 2020 ratio 12.9x
2020 yield 4.77%
Capitalization 6,889 million
247 million
247 million
VE / Sales 2019 1.36x
VE / Sales 2020 1.40x
Number of employees
Free float 42.7%

Chart STANDARD CHEM & PHARM CO., LTD.
Duration :

Period:

Standard Chem & Pharm CO., LTD.  Technical Analysis Table |  MarketScreener

Trends in Technical Analysis STANDARD CHEM & PHARM CO., LTD.

Short term Mid Road Long term
Tendencies Bullish Bearish Neutral

Evolution of the income statement

Leave A Reply

Your email address will not be published.